Table: Taiko Pharmaceutical -2025 group results

Taiko Pharmaceutical Co

13/02/2026 06:45

Feb 13 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Dec 31, 2025    Dec 31, 2024   Dec 31, 2026     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           6.40            6.29           7.20                  
               (+1.7 pct)      (+2.8 pct)     (+12.5 pct)              
  Operating      459 mln         629 mln        500 mln                
               (-27.1 pct)                    (+8.9 pct)               
  Recurring      482 mln         688 mln        520 mln                
               (-29.8 pct)                    (+7.7 pct)               
  Net
  Net            923 mln         898 mln        550 mln                
               (+2.8 pct)                     (-40.4 pct)              
  EPS           18.38 yen       17.90 yen      10.95 yen               
  Ann Div       3.30 yen           NIL         3.50 yen                
  -Q2 Div          NIL             NIL            NIL                  
  -Q4 Div       3.30 yen           NIL         3.50 yen                
  
  NOTE - Taiko Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T